Vaxcyte Executive Executes Stock Sale via Pre-Scheduled Trading Plan
Jim Wassil, the Chief Operating Officer of Vaxcyte, Inc. (NASDAQ: PCVX), has completed a sale of company common stock totaling $127,869. The transaction, which took place on May 1, 2026, involved the disposal of 2,250 shares. These shares were sold at prices ranging from $56.425 to $57.26 per share, representing a weighted average price of $56.831 …